Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Photodynamic therapy with Metvix cream for moderate inflammatory acne vulgaris
2004-002367-24Phase 2Completed
- Sponsor
- Photocure
- Start
- Sep 2004
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in acne vulgaris comparing Metvix photodynamic therapy side with Placebo photodynamic therapy side (2 arms). Primary endpoint: Percent reduction in inflammatory lesion count from baseline. Started Sep 2004; status: completed.
02
Drugs
methyl aminolevulinate
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on 2004-002367-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002367-24.